We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$15.4M
Cap. Flow
+$9.59M
Cap. Flow %
5.87%
Top 10 Hldgs %
57.69%
Holding
80
New
15
Increased
17
Reduced
17
Closed
15

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.45M
2
BIIB icon
Biogen
BIIB
+$1.36M
3
VIR icon
Vir Biotechnology
VIR
+$972K
4
BABA icon
Alibaba
BABA
+$611K
5
PRTA icon
Prothena Corp
PRTA
+$536K

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$3.37M
2
TPB icon
Turning Point Brands
TPB
+$1.83M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$1.82M
4
NFLX icon
Netflix
NFLX
+$1M
5
PYPL icon
PayPal
PYPL
+$499K

Sector Composition

Rank Sector Weight
1 Healthcare 39.59%
2 Technology 13.98%
3 Communication Services 7.11%
4 Consumer Discretionary 3.08%
5 Energy 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$25.2M 15.41%
61,500
+30,000
+95% +$12M
ABBV icon
2
AbbVie
ABBV
$443B
$11.5M 7.02%
72,000
– –
ARGX icon
3
argenx
ARGX
$54.6B
$9.58M 5.86%
25,700
+700
+3% +$259K
MU icon
4
Micron Technology
MU
$930B
$9.5M 5.82%
157,500
+2,500
+2% +$146K
REGN icon
5
Regeneron Pharmaceuticals
REGN
$78.5B
$9.06M 5.55%
11,025
+125
+1% +$94.3K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.36T
$8.42M 5.16%
81,000
-1,000
-1% -$96.6K
ITCI
7
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.42M 3.93%
118,600
-37,650
-24% -$1.82M
XNCR icon
8
Xencor
XNCR
$1.5B
$5.86M 3.59%
210,000
+4,027
+2% +$124K
ET icon
9
Energy Transfer Partners
ET
$70.1B
$4.66M 2.86%
374,000
+6,500
+2% +$82.1K
PRTA icon
10
Prothena Corp
PRTA
$425M
$4.08M 2.5%
84,250
+10,150
+14% +$536K
ORCL icon
11
Oracle
ORCL
$374B
$4M 2.45%
43,000
– –
BAC icon
12
Bank of America
BAC
$435B
$3.95M 2.42%
138,000
-102,000
-43% -$3.37M
GLD icon
13
SPDR Gold Trust
GLD
$131B
$3.94M 2.41%
21,500
-2,500
-10% -$440K
IAU icon
14
iShares Gold Trust
IAU
$62.9B
$3.74M 2.29%
100,000
– –
INCY icon
15
Incyte
INCY
$24.2B
$3.07M 1.88%
42,500
-1,500
-3% -$117K
AMD icon
16
Advanced Micro Devices
AMD
$776B
$2.94M 1.8%
30,000
– –
LLY icon
17
Eli Lilly
LLY
$1.02T
$2.83M 1.73%
8,250
– –
SGEN
18
DELISTED
Seagen Inc. Common Stock
SGEN
$2.46M 1.51%
12,150
-300
-2% -$48.1K
T icon
19
AT&T
T
$159B
$2.45M 1.5%
127,500
-15,000
-11% -$287K
AAPL icon
20
Apple
AAPL
$4.54T
$2.43M 1.49%
14,750
– –
AMGN icon
21
Amgen
AMGN
$208B
$2.42M 1.48%
+10,000
New +$2.45M
AOD
22
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$2.05M 1.25%
253,500
-18,500
-7% -$150K
JQC icon
23
Nuveen Credit Strategies Income Fund
JQC
$705M
$1.86M 1.14%
364,000
+52,580
+17% +$276K
GDXJ icon
24
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$1.78M 1.09%
45,000
– –
TPB icon
25
Turning Point Brands
TPB
$1.45B
– –
-83,113
Closed -$1.83M
1
2 3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, DCF Advisers held 80 positions worth $163M, up 10% from $148M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

DCF Advisers deployed $9.59M of net new capital in Q1 2023, opening 15 new positions and adding to 17 existing holdings. Its largest new stake was Amgen: 10,000 shares worth $2.42M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bank of America, an estimated $3.37M trimmed.

  • DCF Advisers's largest Q1 2023 buy was Amgen: 10,000 shares worth $2.42M.
  • DCF Advisers added most to Vir Biotechnology in Q1 2023, an estimated $972K increase.
  • DCF Advisers's biggest Q1 2023 reduction was Bank of America, cutting an estimated $3.37M.
  • DCF Advisers fully exited Turning Point Brands in Q1 2023, selling an estimated $1.83M.
  • DCF Advisers's ten largest holdings make up 58% of its $163M portfolio in Q1 2023.
  • DCF Advisers opened 15 new positions and closed 15 in Q1 2023.
  • DCF Advisers's portfolio value rose 10% quarter-over-quarter to $163M.

Based on DCF Advisers's 13F filing for Q1 2023, filed 15 May 2023.